Federal grants to GEL4MED Inc
GEL4MED Inc in Newtonville, Massachusetts received $6.0 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Diabetes, Digestive, and Kidney Diseases Extramural Research, with $2.6 million. In fiscal 2025 it was awarded $1.1 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$6.0 million
- Awards5
- Awarded in FY 2025$1.1 million
- Largest award$2.6 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $1.0 million |
| FY 2022 | 1 | $50,000 |
| FY 2023 | 2 | $2.3 million |
| FY 2024 | 1 | $1.5 million |
| FY 2025 | 1 | $1.1 million |
Programs that fund GEL4MED Inc
| Program | Awards | Amount |
|---|---|---|
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $2.6 million |
| Biomedical Research and Research Training | 2 | $2.2 million |
| Allergy and Infectious Diseases Research | 1 | $1.1 million |
| Vision Research | 1 | $29,697 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 5 | $6.0 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Antimicrobial dermal matrices to promote infection free wound closure in dtu-dfus. - project summary/abstract dfus will affect more than 30% of diabetic patients within their lifetime and costs the us healthcare system over $20 billion annually. Many dfus fail to heal effectively and require extensi | Diabetes, Digestive, and Kidney Diseases Extramural Research | August 31, 2023 | $2.6 million |
| Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds - overview: this crp project aims at enabling regulatory clearance/approval and accelerating commercial availability of a self-assembly peptide-based matrix (G4DERM) for the management of wounds. Wound care is | Biomedical Research and Research Training | September 7, 2023 | $1.2 million |
| Novel dermal templates for prevention and treatment of biofilms in cutaneous wounds - project summary the goal of this phase II sbir proposal is to further develop an anti-biofilm, peptide-based, tissue- scaffolding matrix, G4B, for preventing and eliminating biofilms from acute and chronic wounds. | Allergy and Infectious Diseases Research | June 17, 2025 | $1.1 million |
| Antimicrobial dermal matrices to promote infection free wound closure in cutaneous wounds | Biomedical Research and Research Training | March 22, 2021 | $1.0 million |
| Treatment of microbial keratitis and corneal wound healing | Vision Research | November 17, 2020 | $29,697 |
Questions people ask
How much federal grant money does GEL4MED Inc get?
$6.0 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives GEL4MED Inc the most?
The Department of Health and Human Services, with $6.0 million in 5 awards.
What is GEL4MED Inc's largest federal grant?
$2.6 million under Diabetes, Digestive, and Kidney Diseases Extramural Research, with its first action in the period on August 31, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund GEL4MED Inc?
Its largest are Diabetes, Digestive, and Kidney Diseases Extramural Research, Biomedical Research and Research Training and Allergy and Infectious Diseases Research.
Other grant recipients in Newtonville
Largest federal grant recipients in Massachusetts · Federal grants in Massachusetts